Levin Capital Strategies’s Labcorp LH Stock Holding History

Levin Capital Strategies’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.47M	Sell	12,400 -8,613	-41%	-$2.26M	0.23%	87
2026 Q1	$5.61M	Buy	+21,013	New	+$5.69M	0.43%	67
2023 Q3	–	Sell	-94,281	Closed	-$19.5M	–	293
2023 Q2	$19.5M	Sell	94,281 -4,725	-5%	-$917K	2.22%	15
2023 Q1	$19.5M	Buy	+99,006	New	+$20.4M	2.42%	13
2021 Q4	–	Sell	-1,065	Closed	-$258K	–	371
2021 Q3	$258K	Hold	1,065	–	–	0.03%	249
2021 Q2	$252K	Hold	1,065	–	–	0.03%	247
2021 Q1	$233K	Buy	+1,065	New	+$214K	0.02%	228
2018 Q4	–	Sell	-19,788	Closed	-$2.95M	–	280
2018 Q3	$2.95M	Sell	19,788 -2,328	-11%	-$354K	0.05%	89
2018 Q2	$3.41M	Sell	22,116 -2,503	-10%	-$378K	0.06%	88
2018 Q1	$3.42M	Buy	24,619 +22,873	+1,310%	+$3.36M	0.06%	90
2017 Q4	$239K	Buy	+1,746	New	+$231K	﹤0.01%	259
2016 Q4	–	Sell	-6,402	Closed	-$756	–	319
2016 Q3	$756	Buy	6,402 +1,746	+38%	+$206K	0.01%	193
2016 Q2	$521K	Buy	+4,656	New	+$501K	0.01%	220

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Levin Capital Strategies's LH Position: Q2 2026 in Review

Levin Capital Strategies reduced its Labcorp (LH) stake by 41% in Q2 2026, selling an estimated $2.26M and leaving 12,400 shares worth $3.47M. The position accounts for 0.23% of the portfolio, ranked #87.

Levin Capital Strategies first reported a position in LH in Q2 2016 and has held it in 13 quarters since. The position peaked at $19.5M in Q2 2023. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

Levin Capital Strategies held 12,400 shares of Labcorp worth $3.47M as of Q2 2026.
Levin Capital Strategies sold 8,613 Labcorp shares in Q2 2026, an estimated $2.26M.
Labcorp made up 0.23% of Levin Capital Strategies's portfolio in Q2 2026, its #87 holding.
Levin Capital Strategies first reported a position in Labcorp in Q2 2016 and has held it in 13 quarters since.
Levin Capital Strategies's Labcorp position peaked at $19.5M in Q2 2023.
1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Levin Capital Strategies's 13F filing for Q2 2026, filed 31 Jul 2026.